Published in Cancer Weekly, August 23rd, 2005
"Thymidine kinase is involved in nucleic acid synthesis and is, therefore, considered to be an important proliferation tumor marker. For this reason, we monitored this marker in the course of colorectal cancer chemotherapy. We examined TK levels in 30 patients with colorectal cancer who underwent adjuvant or palliative chemotherapy (CHT schemes)," scientists writing in the journal Anticancer Research reported.
"The condition for being included in the study was a minimum of 3 cycles of chemotherapy. TK was always...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.